Skip to content

Study on the therapeutic effect and mechanism of traditional Chinese medicine combined with enteral nutrition on the reduction of skeletal muscle content caused by chemotherapy in patients with advanced lung cancer

Study on the therapeutic effect and mechanism of traditional Chinese medicine combined with enteral nutrition on the reduction of skeletal muscle content caused by chemotherapy in patients with advanced lung cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104777
Enrollment
Unknown
Registered
2025-06-23
Start date
2023-10-17
Completion date
Unknown
Last updated
2025-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

Control group:Advanced first-line anti-tumor therapy
Traditional Chinese Medicine Group:Adding traditional Chinese medicine treatment on the basis of advanced first-line standard anti-tumor treatment
Enteral nutrition group:Adding enteral nutrition therapy on the basis of advanced first-line standard anti-tumor treatment
Joint group:Advanced first-line standard anti-tumor treatment increases traditional Chinese medicine and enteral nutrition therapy

Sponsors

Lishui Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients with stage IIIB and IV non-small cell lung squamous cell carcinoma who have not undergone chemotherapy in the past and require the use of paclitaxel combined with platinum chemotherapy, and are able to successfully complete the above four courses of treatment; 2. The characteristics of the syndrome meet the diagnostic criteria of traditional Chinese medicine mentioned above; 3. Age range: 18-70 years old; 4. 4<PG-SGA <= 8 points; 5. WHO PS score ranges from 0 to 1; 6. There are no significant abnormalities in liver and kidney function; 7. Expected survival period is greater than 6 months.

Exclusion criteria

Exclusion criteria: 1. Patients with mental illness and those who are confused and unable to communicate verbally; 2. Serious organic or functional lesions of organs such as liver, kidney, heart and brain; 3. Pregnant and lactating women; 4. Within the past 3 months, there have been confirmed cases of other intestinal diseases; 5. Patients who have used antibiotics or probiotics in the past 3 months; 6. Diabetes patients with poor blood glucose control; 7. Patients with combined malignant tumors; 8. Patients with autoimmune diseases;

Design outcomes

Primary

MeasureTime frame
L3 skeletal muscle index;Daily activity level;

Secondary

MeasureTime frame
nutritional status;Changes in immune function;Clinical syndrome information;Changes in gut microbiota;

Countries

China

Contacts

Public ContactZhang Xinjie

Lishui Central Hospital

differentzxj@163.com+86 178 5890 3607

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026